Clinical Trial Update: Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients [Phase 3]

View source ↗

Summary

An open-label Phase 3 follow-up study evaluating the fixed-dose combination of telmisartan and hydrochlorothiazide in patients with hypertension; the trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan/hydrochlorothiazide (fixed-dose combination) (Telmisartan and hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED